Supporters so far
HOOFING IT! 2026 Total so far $10,685
Start Hoofing It! Registration is open join a team or start your own Register Now
2025 Results Together we raised $40,662 — thank you to all 150 donors & 11 teams Donate Today
Why It Matters Every step funds NET research, drug access, & patient support across Canada Learn More
Sponsor a Walker Can’t walk? Sponsor a team member — every dollar counts Sponsor Now
2026 Total So Far $10,685 raised of $60,000 — keep on HOOFING IT! Donate Now
HOOFING IT! 2025:
Raised $40,662!

Health Canada approves XERMELO™ (telotristat ethyl)

Health Canada approves XERMELO™ (telotristat ethyl) for the treatment of adult patients suffering from refractory carcinoid syndrome diarrhea(1) "XERMELOTM is a novel, orally administered, inhibitor of the enzyme tryptophan hydroxylase [...]

By |2018-10-17T14:45:09-04:00October 17th, 2018|Treatment News|Comments Off on Health Canada approves XERMELO™ (telotristat ethyl)
Go to Top